Acidic extraction of the stem bark and roots of Chione venosa (SW.) URBAN var. venosa, purchased in Grenada under the vernacular name Bois Bandé, led to the isolation of two new substances of the oxynorneolignan-type. Moreover, TLC-and HPLC-systems were developed in order to determine these substances in crude extracts. Analytical data are indicated for the new compounds, as well as for those substances which were published recently. In the different Caribbean islands different plant sources are used to furnish the aphrodisiac Bois Bandé. On the basis of the presented analytical systems, 14 different samples of Bois Bandé (stem bark and/or root) that were either purchased from local traders or collected at different sites in the Grenadian forest were examined. In addition, an entire macroscopic and microscopic description of the drug is given which, in combination with the phytochemical data, provides a powerful tool to assess the quality of the drug material with regard to its botanical homogeneity.
Bois Bandé is a quite popular Caribbean aphrodisiac of plant origin. The used plant sources may vary greatly, because different species are collected under this name in the different West Indian islands [1] . In Grenada, the stem bark and roots of Chione venosa (SW.) URBAN var. venosa, a native tree of the island's rain forest, are traded as Bois Bandé. Preliminary investigations of Bois Bandé from Grenada showed the presence of phenolic and terpenoid compounds of the iridoid and acetophenone type (3) (4) (5) (6) (7) (8) [2] . In continuation of our previous work, we report the isolation and elucidation of two other structures, as well as the results of the chemical and microscopic screening of various drug samples. We purchased samples of the crude drug from various local traders in different years and collected authentic samples of stem bark and root at different sites in the Grenadian forest (see Table 1 ).
The plant material was extracted under acidic conditions with dichloromethane and methanol-water following the same procedure as in our previous work [2] . Separation by repeated column chromatography and purification by preparative TLC yielded 2.7 mg of compound 1 and 3.4 mg of compound 2 (see Figure 1 ).
The LC-MS of both substances were recorded in the negative mode, showing quasi molecular ions [M-H] − at m/z 521 (1) and 551 (2) . In both cases, a fragment with a mass difference of 180 amu due to a hexose could be observed. The 1 H and 13 C NMR spectra confirmed this result showing the typical signals of a β-linked glucose. The other signals led to an aromatic system of the oxynorneolignan-type. The only difference between the two compounds was an additional methoxy-group in compound 2. The 1 H and 13 C NMR spectroscopic data of the aglycone part (1, 2) , iridoids (3) (4) (5) and acetophenones (6-8).
of 1 and 2 were nearly identical to those of a known curlignan [3] , but differences in the NMR-shifts of C-3 and C-9 suggested an alteration in the position of the side chain. The relative stereochemistry was determined by selective NOE experiments: NOEs were induced from the H-2 doublet to H-2' and H-6'; irradiation at the resonance of H-9a gave a nuclear Overhauser effect at H-2, H-4 and H-1''. These results indicated that H-2 and H-3 are trans-oriented [3] . In addition, the observed coupling constants were in perfect accordance with the calculated structures generated from energy minimum computations using the MM+ force field.
The absolute stereochemistry of 1 and 2 was determined by comparison of its CD curve with that of 2S,3R-(+)-curlignan [3] and 2S,3R-(+)-dehydrodiconiferyl alcohol [4] . The aglycone of 1 shows the same relative stereochemistry, but exactly opposite CD effects. Considering the trans substitution in positions 2 and 3 and the opposite CD effects to our reference samples, compound 1 can be established as 2R,3S-(−)-curlignan-3-O-β-glucopyranoside, and compound 2 as its 5'-methoxy-derivative. Both structures are new; only the aglycone of compound 1 has been described so far.
Owing to the crude drug's striking aromatic odor, dichloromethane extracts of the crude drug, as well as n-hexane extracts and ethyl acetate extracts of the steam distillate were prepared to detect the responsible volatile compounds. The analyses by GC-EI-MS and TLC showed one dominating compound. It was identified as 2-hydroxyacetophenone (6) by comparison with the spectra in our library. It may be regarded as the corresponding aglycone of the compounds 7 and 8, substituted with an oxygen function in position 2. This compound is highly volatile and evaporates from the TLC plate at room temperature within 48 hours. During storage its content in the crude drug decreases. This compound has not yet been described for C. venosa.
In a further approach, a 40% methanolic extract was prepared and separated by column chromatography on silica gel yielding a crystalline substance, possibly a sugar (9). Using trimethylsilylated sugars as references, the GC-MS analysis of the trimethylsilylated substance revealed its structure as α-methyl-D-glucopyranoside. The retention times, as well as the respective mass spectra, were in perfect accordance with those of the reference substance.
HPLC was employed to analyze methanolic and methanolic-aqueous extracts. The compounds were identified according to the retention times of cochromatographed authentic substances and to on-line recorded UV-and mass spectra. Compared to the stem bark, the roots seem to contain higher amounts of 2-O-apio-glucosyl-acetophenone (8), which was also discernible by TLC. Figure 2 shows the TLC of twelve samples of the stem bark and nine samples of the roots. Most of the samples show similar qualitative composition, but differences in quantity (estimated semi-quantitatively by band size). The differences in the quantitative composition of the stem bark and roots could also be demonstrated by GC. Similar to the results from HPLC and TLC, a higher amount of 8 than 6 could be detected in the roots.
In summary, the comparatively homogenous chemical composition of the stem bark and roots indicates that the local collectors exclusively use C. venosa to provide the drug "Bois Bandé".
In addition to the chemical analyses, the drug was also subjected to microscopic investigations. The stem bark and the roots of C. venosa are light brown in color and have a typical aromatic odor. The anatomical characteristics of the stem bark encompass clusters of stone cells and fibers in the primary and secondary cortex and crystals in the parenchyma. Most parenchyma cells are filled with minute crystal sand, while the cells of the innermost row of the cork tissue only contain single prismatic crystals. The bark of the roots shows similar characteristics. In older organs, clusters of stone cells and fibers are found in the primary cortex; only younger roots differ by having short fibers and few stone cells in this layer. In the secondary cortex, mostly fibers are produced. Crystal sand appears in the parenchyma cells and single crystals are also found in the cork layer. The solid xylum consists of pitted vessels, pitted fibers and pitted parenchyma cells. All investigated market samples exhibited the same anatomical features as the authentic drug specimens. Hence, according to the microscopic studies, no other plant source than C. venosa was used to furnish Bois Bandé.
Including the previously reported results, we could detect nine compounds in the extracts of C. venosa. The chemical and microscopic analyses showed a similar pattern for all the samples. These results led to the conclusion that, in Grenada, C. venosa is the sole source of the aphrodisiac Bois Bandé. Table 1 ). Extraction and isolation: Bark (274 g) was moistened with 4N HCl (240 mL), neutralized with conc. NH 3 (100 mL) and extracted with CH 2 Cl 2 (1L) for 1.5 h under reflux; this extraction was repeated three times. After filtration, CH 2 Cl 2 was removed under reduced pressure leading to an oily extract (E1) and a residue (R1). E1 was redissolved in 2N HCl at 45° (x 3, 40 mL/10 mL/10 mL), filtered, alkalized with conc. NH 3 to pH 9-10, and extracted with CH 2 Cl 2 yielding 222 mg of extract E2. R1 was extracted with MeOH-H 2 O 1:1 for 1.5 h under reflux (x 4). The dried extract was redissolved in 2N HCl (300 mL), alkalized with conc. NH 3 to pH 9-10 and extracted with CH 2 Cl 2 , yielding 1.6 g of extract E3.
Experimental
E2 and E3 were separated by CC on Sephadex LH-20 with iso-propanol into seven fractions (I-VII); fraction V was further purified by CC on C18 with MeOH 70% (v/v) (fractions V/1-V/6). Fraction V/1 was then separated by CC on silica gel with CHCl 3 -MeOH (9:1) (fractions V/1/1-V/1/4). Fraction V/1/2 contained a mixture of 1 and 2, which was separated by preparative TLC on silica gel (toluene-acetonemethanol-ammonia 4.5:4.5:0.7:0.3), followed by a final purification by CC on silica gel with CHCl 3 -MeOH (9:1). The compounds were obtained in amounts of 2.7 mg (1) and 3.4 mg (2), respectively.
Powdered bark (50 g) was mixed with 40% MeOH (v/v, 500 mL) and kept at room temperature for one week. Concentration of the MeOH extract was performed in vacuo adding n-BuOH to remove the water. The extract yield was 12 g, of which 3.15 g was separated by CC on silica gel into ten fractions (I-X); compound 9 crystallized from fraction VIII. Powdered drug (0.05 g) was extracted with 0.5 mL CH 2 Cl 2 in an ultrasonic bath for 10 min. After filtration, the CH 2 Cl 2 was removed under reduced pressure. The extract was redissolved in 50 µL CH 2 Cl 2 , of which 2 µL was injected. Before analysis, a few crystals of compound 9 and the reference sugars were subjected to acidic hydrolysis with Kiliani reagent (1.75 mL CH 3 COOH conc., 0.5 mL HCl conc., 2.75 mL water) for 2 h at 100°C. The dried residue was redissolved in 100 µL pyridine (dried) and trimethylsilylated by addition of 40 µL hexamethyl-disilazane and 50 µL trimethylchlorosilane; 1 µL of the solution was injected. (1) [α] D : -34.0º (c 0.05, MeOH 
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